business

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Bloomberg Markets · May 6, 2026, 1:00 AM · Also reported by 4 other sources

Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the matter.

Read full story on Bloomberg Markets → More top stories

Also covered by

Investing.com Royalty Pharma earnings in focus as deal activity accelerates Yahoo Finance Bullish Shares Pop on $4.2 Billion Deal to Acquire Transfer Agent Equiniti Decrypt Bullish Shares Pop on $4.2 Billion Deal to Acquire Transfer Agent Equiniti Fortune White House estimates Trump’s Big Pharma dealmaking will save Americans $529 billion over the next 10 years

Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Also covered by

More in business